United States Vaccines Market Report 2017

November 2017 | 112 pages | ID: UB0FA8AF7CEWEN
QYResearch

Abstracts

In this report, the United States Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest

with sales (volume), revenue (value), market share and growth rate of Vaccines in these regions, from 2012 to 2022 (forecast).
United States Vaccines market competition by top manufacturers/players, with Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Sanofi
• Merck
• Pfizer
• Novartis(GSK)
• CSL
• MedImmune
• J&J?Crucell)
• China National Biotec
• Tiantan
• Hualan
• Kangtai
• Hissen
• Jintan

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Recombinant Vaccines
• Viral Vaccines
• Polysaccharide Vaccines
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Vaccines for each application, including

• Adult
• Children

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Vaccines Market Report 2017

1 VACCINES OVERVIEW

1.1 Product Overview and Scope of Vaccines
1.2 Classification of Vaccines by Product Category
  1.2.1 United States Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Recombinant Vaccines
  1.2.4 Viral Vaccines
  1.2.5 Polysaccharide Vaccines
  1.2.6 Other
1.3 United States Vaccines Market by Application/End Users
  1.3.1 United States Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Adult
  1.3.3 Children
1.4 United States Vaccines Market by Region
  1.4.1 United States Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Vaccines (2012-2022)
  1.5.1 United States Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Vaccines Market Competitive Situation and Trends
  2.4.1 United States Vaccines Market Concentration Rate
  2.4.2 United States Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Vaccines Price by Region (2012-2017)

4 UNITED STATES VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Vaccines Price by Type (2012-2017)
4.4 United States Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis(GSK)
  6.5.2 Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 CSL
  6.6.2 Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 MedImmune
  6.7.2 Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 MedImmune Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 J&J?Crucell)
  6.8.2 Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 J&J?Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 China National Biotec
  6.9.2 Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Tiantan
  6.10.2 Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Hualan
6.12 Kangtai
6.13 Hissen
6.14 Jintan

7 VACCINES MANUFACTURING COST ANALYSIS

7.1 Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Vaccines
Figure United States Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Recombinant Vaccines Product Picture
Figure Viral Vaccines Product Picture
Figure Polysaccharide Vaccines Product Picture
Figure Other Product Picture
Figure United States Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Vaccines by Application in 2016
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure Children Examples
Table Key Downstream Customer in Children
Figure United States Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Vaccines Sales Share by Players/Suppliers
Figure United States Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Vaccines Revenue Share by Players/Suppliers
Table United States Market Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Vaccines Product Category
Table United States Vaccines Sales (K Units) by Region (2012-2017)
Table United States Vaccines Sales Share by Region (2012-2017)
Figure United States Vaccines Sales Share by Region (2012-2017)
Figure United States Vaccines Sales Market Share by Region in 2016
Table United States Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Vaccines Revenue Share by Region (2012-2017)
Figure United States Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Vaccines Revenue Market Share by Region in 2016
Table United States Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Vaccines Sales (K Units) by Type (2012-2017)
Table United States Vaccines Sales Share by Type (2012-2017)
Figure United States Vaccines Sales Share by Type (2012-2017)
Figure United States Vaccines Sales Market Share by Type in 2016
Table United States Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Vaccines by Type (2012-2017)
Figure Revenue Market Share of Vaccines by Type in 2016
Table United States Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Vaccines Sales (K Units) by Application (2012-2017)
Table United States Vaccines Sales Market Share by Application (2012-2017)
Figure United States Vaccines Sales Market Share by Application (2012-2017)
Figure United States Vaccines Sales Market Share by Application in 2016
Table United States Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Vaccines Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Vaccines Sales Growth Rate (2012-2017)
Figure GSK Vaccines Sales Market Share in United States (2012-2017)
Figure GSK Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Vaccines Sales Growth Rate (2012-2017)
Figure Merck Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Vaccines Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Vaccines Sales Growth Rate (2012-2017)
Figure Pfizer Vaccines Sales Market Share in United States (2012-2017)
Figure Pfizer Vaccines Revenue Market Share in United States (2012-2017)
Table Novartis(GSK) Basic Information List
Table Novartis(GSK) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis(GSK) Vaccines Sales Growth Rate (2012-2017)
Figure Novartis(GSK) Vaccines Sales Market Share in United States (2012-2017)
Figure Novartis(GSK) Vaccines Revenue Market Share in United States (2012-2017)
Table CSL Basic Information List
Table CSL Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Vaccines Sales Growth Rate (2012-2017)
Figure CSL Vaccines Sales Market Share in United States (2012-2017)
Figure CSL Vaccines Revenue Market Share in United States (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MedImmune Vaccines Sales Growth Rate (2012-2017)
Figure MedImmune Vaccines Sales Market Share in United States (2012-2017)
Figure MedImmune Vaccines Revenue Market Share in United States (2012-2017)
Table J&J?Crucell) Basic Information List
Table J&J?Crucell) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure J&J?Crucell) Vaccines Sales Growth Rate (2012-2017)
Figure J&J?Crucell) Vaccines Sales Market Share in United States (2012-2017)
Figure J&J?Crucell) Vaccines Revenue Market Share in United States (2012-2017)
Table China National Biotec Basic Information List
Table China National Biotec Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure China National Biotec Vaccines Sales Growth Rate (2012-2017)
Figure China National Biotec Vaccines Sales Market Share in United States (2012-2017)
Figure China National Biotec Vaccines Revenue Market Share in United States (2012-2017)
Table Tiantan Basic Information List
Table Tiantan Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tiantan Vaccines Sales Growth Rate (2012-2017)
Figure Tiantan Vaccines Sales Market Share in United States (2012-2017)
Figure Tiantan Vaccines Revenue Market Share in United States (2012-2017)
Table Hualan Basic Information List
Table Kangtai Basic Information List
Table Hissen Basic Information List
Table Jintan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vaccines
Figure Manufacturing Process Analysis of Vaccines
Figure Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Vaccines
Table Distributors/Traders List
Figure United States Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources